Irina Kadiyala
Senior Director & Head, Heme Process Development • Vertex Cell and Gene Therapies
Irina Kadiyala has more than 22 years of industrial experience and in the current position, she heads the Heme Process Development group at Vertex Cell Gene Therapies. She is responsible for enabling process validation studies and their execution relying on her expertise in aseptic cell manufacturing.
Irina has Ph.D. in Biophysics.
Also Speaking
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023
